[
  {
    "ts": "2025-09-02T15:06:54+00:00",
    "headline": "Medtronic advances Abbott partnership with FDA nod",
    "summary": "The company received FDA authorization to pair its 780G insulin pump with a glucose sensor made by Abbott, and to use the device for Type 2 diabetes.",
    "url": "https://www.medtechdive.com/news/medtronic-fda-authorize-780g-abbott/759049/",
    "source": "MedTech Dive",
    "provider": "yfinance",
    "raw": {
      "id": "37231ba8-87d9-34ef-b113-daebcd164dbc",
      "content": {
        "id": "37231ba8-87d9-34ef-b113-daebcd164dbc",
        "contentType": "STORY",
        "title": "Medtronic advances Abbott partnership with FDA nod",
        "description": "",
        "summary": "The company received FDA authorization to pair its 780G insulin pump with a glucose sensor made by Abbott, and to use the device for Type 2 diabetes.",
        "pubDate": "2025-09-02T15:06:54Z",
        "displayTime": "2025-09-02T15:06:54Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medtech_dive_335/750fdf53cb35947d5f0ce8a43a826421",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "MedTech Dive, an Industry Dive publication",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CfiwZcqajD6GIrfQSU8QEw--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medtech_dive_335/750fdf53cb35947d5f0ce8a43a826421.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jrfLJxLAsCtfuwsqFT5_ww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medtech_dive_335/750fdf53cb35947d5f0ce8a43a826421.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MedTech Dive",
          "url": "https://medtechdive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medtechdive.com/news/medtronic-fda-authorize-780g-abbott/759049/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/medtronic-advances-abbott-partnership-fda-150654632.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MDT"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-02T12:45:00+00:00",
    "headline": "FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes",
    "summary": "Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden the MiniMed™ 780G system portfolio: clearance of the SmartGuard™ algorithm as an interoperable automated glycemic controller (iAGC), enabling integration with the Instinct sensor, made by Abbott, for type 1 diabetes, and approval of the MiniMed™ 780G system for use in adults 18+ with insulin-requiring type 2 diabetes.",
    "url": "https://finance.yahoo.com/news/fda-clears-minimed-780g-system-124500754.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "1d8f9fb6-332c-394f-8ca2-d04331865931",
      "content": {
        "id": "1d8f9fb6-332c-394f-8ca2-d04331865931",
        "contentType": "STORY",
        "title": "FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes",
        "description": "",
        "summary": "Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden the MiniMed™ 780G system portfolio: clearance of the SmartGuard™ algorithm as an interoperable automated glycemic controller (iAGC), enabling integration with the Instinct sensor, made by Abbott, for type 1 diabetes, and approval of the MiniMed™ 780G system for use in adults 18+ with insulin-requiring type 2 diabetes.",
        "pubDate": "2025-09-02T12:45:00Z",
        "displayTime": "2025-09-02T12:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/49a85cbd9b6b6669e9b3c414a6982ebf",
          "originalWidth": 400,
          "originalHeight": 225,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QANtiwB6KM2ndGTQsGitMQ--~B/aD0yMjU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/49a85cbd9b6b6669e9b3c414a6982ebf.cf.webp",
              "width": 400,
              "height": 225,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/34fkE8QSD5DJ_Y959l0WrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/49a85cbd9b6b6669e9b3c414a6982ebf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fda-clears-minimed-780g-system-124500754.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-clears-minimed-780g-system-124500754.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "MDT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-02T11:59:00+00:00",
    "headline": "Hemato-Oncology Testing Market Size, Share & Trends Analysis Report 2025-2030 Featuring Key Players Roche, Abbott, EntroGen, Qiagen, and Cepheid (Danaher) Among Others",
    "summary": "Opportunities in the hemato-oncology testing market include rising lymphoma and myeloma cases, personalized therapy demand, and advanced molecular diagnostics. Emerging technologies like single-cell sequencing and long-read sequencing enhance diagnostic precision, thus driving market growth and improving patient outcomes. Hemato Oncology Testing Market Hemato Oncology Testing Market Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The \"Hemato-Oncology Testing Market Size, Share & Trends Analysis 2025-",
    "url": "https://finance.yahoo.com/news/hemato-oncology-testing-market-size-115900882.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "a48e9ac0-9d38-3f44-afc9-043e69ed3ac7",
      "content": {
        "id": "a48e9ac0-9d38-3f44-afc9-043e69ed3ac7",
        "contentType": "STORY",
        "title": "Hemato-Oncology Testing Market Size, Share & Trends Analysis Report 2025-2030 Featuring Key Players Roche, Abbott, EntroGen, Qiagen, and Cepheid (Danaher) Among Others",
        "description": "",
        "summary": "Opportunities in the hemato-oncology testing market include rising lymphoma and myeloma cases, personalized therapy demand, and advanced molecular diagnostics. Emerging technologies like single-cell sequencing and long-read sequencing enhance diagnostic precision, thus driving market growth and improving patient outcomes. Hemato Oncology Testing Market Hemato Oncology Testing Market Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The \"Hemato-Oncology Testing Market Size, Share & Trends Analysis 2025-",
        "pubDate": "2025-09-02T11:59:00Z",
        "displayTime": "2025-09-02T11:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/82bb959f410100f81585888bd9022732",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Hemato Oncology Testing Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oMGhY0BijxOSzXiEw4HBnw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/82bb959f410100f81585888bd9022732.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SUkzlMAKTQKdIFiOf1xhQw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/82bb959f410100f81585888bd9022732.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hemato-oncology-testing-market-size-115900882.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hemato-oncology-testing-market-size-115900882.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ROG.SW"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-02T07:15:00+00:00",
    "headline": "Defence Therapeutics Engages Dr. Amie Phinney as Strategy & Business Advisor to Guide Next Phase of Growth",
    "summary": "Montreal, Quebec--(Newsfile Corp. - September 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (\"Defence\" or the \"Company\"), a leading biotechnology company specialized in drug delivery technologies, is pleased to announce the engagement of Amie Phinney, PhD, MBA as the Strategy & Business Advisor, effective immediately. Dr. Phinney will work closely with senior leadership to refine and align the company's short- and long-term strategies as it pursues exciting new...",
    "url": "https://finance.yahoo.com/news/defence-therapeutics-engages-dr-amie-071500577.html",
    "source": "Newsfile",
    "provider": "yfinance",
    "raw": {
      "id": "3957e4bb-c195-3e6d-9a8b-b7fd2152415b",
      "content": {
        "id": "3957e4bb-c195-3e6d-9a8b-b7fd2152415b",
        "contentType": "STORY",
        "title": "Defence Therapeutics Engages Dr. Amie Phinney as Strategy & Business Advisor to Guide Next Phase of Growth",
        "description": "",
        "summary": "Montreal, Quebec--(Newsfile Corp. - September 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (\"Defence\" or the \"Company\"), a leading biotechnology company specialized in drug delivery technologies, is pleased to announce the engagement of Amie Phinney, PhD, MBA as the Strategy & Business Advisor, effective immediately. Dr. Phinney will work closely with senior leadership to refine and align the company's short- and long-term strategies as it pursues exciting new...",
        "pubDate": "2025-09-02T07:15:00Z",
        "displayTime": "2025-09-02T07:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/newsfile_64/0c217ca93d80383f622010338d48f44e",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0IR7LlEde2jO8eYuE3lPpA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/0c217ca93d80383f622010338d48f44e.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vZUdk7niGnXUAm24PPfSoQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/0c217ca93d80383f622010338d48f44e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Newsfile",
          "url": "https://www.newsfilecorp.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/defence-therapeutics-engages-dr-amie-071500577.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/defence-therapeutics-engages-dr-amie-071500577.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DTCFF"
            },
            {
              "symbol": "DTC.CN"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]